Remove 2030 Remove Biosimilars Remove Packaging
article thumbnail

Pharmapack Europe to launch two new zones in 2024

European Pharmaceutical Review

In 2024, Pharmapack Europe, the two-day exhibition and conference for pharma’s drug delivery and packaging industry will introduce two brand new zones to the flagship event. Bio packaging zone . Pharmapack’s bio packaging zone builds on its long history of being at the forefront of innovations in biological drug delivery.

article thumbnail

We are well-aligned to capitalise on the CDMO opportunity

Express Pharma

And, since most of the future growth will come from biologics and biosimilars, how will India make its mark as a global biosimilar CDMO market? Our processes are designed to reduce and recycle waste, including solvent recovery systems, minimal-waste chemical reactions, and innovative packaging design.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

17th edition of CPHI & PMEC India inaugurated at India Expo Centre, Noida

Express Pharma

With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Projections indicate exports will soar to $130 billion by 2030 and $450 billion by 2047. With exports nearing $27.84

Packaging 105
article thumbnail

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

Robert Barrie July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Only 4% of global drugs sales in 2030 will have patent protection. A recent report by GlobalData projects that the share of global drug sales under patent protection will decline by 2030. How will RFK Jr’s American dream for vaccines play out?